Description

Summary diagram of all receptor families responsive to phytocannabinoids in the context of epilepsy. The multi-target pharmacology of cannabis-derived compounds differentiates them from conventional single-target antiepileptic drugs.

Figure 277

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 277: Summary diagram of all receptor families responsive to phytocannabinoids in the context of epilepsy. The multi-target pharmacology of cannabis-derived compounds differentiates them from conventional single-target antiepileptic drugs.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Summary diagram of all receptor families responsive to phytocannabinoids in the context of epilepsy. The multi-target pharmacology of cannabis-derived compounds differentiates them from conventional single-target antiepileptic drugs." />
  <figcaption>Figure 277. Summary diagram of all receptor families responsive to phytocannabinoids in the context of epilepsy. The multi-target pharmacology of cannabis-derived compounds differentiates them from conventional single-target antiepileptic drugs.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Preuves associées

CBD pour Insomnie

Note A · 103 études